A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.
Conditions
Periodontitis (Stage 3)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Regenerative Solutions, Fullerton, California, United States
Contact: Principal Investigator (Mylea Hunter, DDS, MS, RDH)Shoreline Periodontics and Dental Implants, New London, Connecticut, United States
Contact: Principal Investigator (Geogory Toback, DMD,MS)The Perio Studio, Boston, Massachusetts, United States
Contact: Study coordinator (Irina Dragan, DMD, DDS, MS, eMBA) · i.dragan@themcguireinstitute.org · 617-523-2459Contact: Principal Investigator (Irina Dragan, DMD, DDS, MS, eMBA)Metro West Orthodontics & Periodontics, La Vista, Nebraska, United States
Contact: Principal Investigator (Takanari Miyamoto, DDS,MBA)Perio Health Professionals, Houston, Texas, United States
Contact: Study coordinator (Michael McGuire, DDS, FICD, FACD) · amrperio@periohealth.com · 713-783-5442Contact: Principal Investigator (Michael McGuire, DDS, FICD, FACD)Perio Health Professionals, Houston, Texas, United States
Contact: Principal Investigator (E. Todd Scheyer, DDS, MS)Periodontal Center of Excellence, PLLC, Spring, Texas, United States
Contact: Study coordinator (Ali Sajadi, DDS, MSD, FACD, FICD) · alisajadi@periocenter.com · 281-292-1833Contact: Principal Investigator (Ali Sajadi, DDS, MDS, FACD, FICD)Glazier Implants + Periodontics, Richmond, Virginia, United States
Contact: Principal Investigator (Thomas Glazier, DDS,MSD)Seattle Periodontist and Implant Dentistry, Seattle, Washington, United States
Contact: Study coordinator (Ashley Hoders, DMD, MSD, FACP) · ashleyhodersdmd@gmail.com · 206-628-0404Contact: Principal Investigator (Ashley Hoders, DMD, MSD, FACP)
Study leads
Jarret Fass
Study Director
Emanate Biomedical